Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

Bristol-Myers Squibb

Sanofi said to be looking at options for $30bn consumer health unit

Sanofi said to be looking at options for $30bn consumer health unit Many have decided either to sell off the divisions in whole or in part – including Novartis, Merck KGaA, Bristol-Myers Squibb and Bayer for example – while GlaxoSmithKline and Pfizer both slimmed

BMS’ Opdivo/Yervoy combination fails to shine in melanoma

BMS’ Opdivo/Yervoy combination fails to shine in melanoma Bristol-Myers Squibb has faced a bump in the road of its expansion plans for Opdivo/Yervoy, after the combination failed to demonstrate a significant benefit in certain high-risk melanoma

MSD’s Keytruda scores another EU okay, in head and neck cancer

MSD’s Keytruda scores another EU okay, in head and neck cancer new treatment option and MSD’s drug another leg up over its rivals in the checkpoint inhibitor category such as Bristol-Myers Squibb’s Opdivo (nivolumab).

J&J’s new Darzalex formulation OK’d for use in Europe

J&J’s new Darzalex formulation OK’d for use in Europe Bristol-Myers Squibb and AbbVie’s already-marketed Empliciti (elotuzumab) is also vying for a larger market share in myeloma.

UPDATED: BMS completes Celgene merger after FTC okay

UPDATED: BMS completes Celgene merger after FTC okay Approval comes over ten months after acquisition announcement. After US regulators finally gave their blessing for Bristol-Myers Squibb's $74bn takeover of Celgene, the acquisition was finally completed on 20 ... This is an exciting day for

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics